Pharmacogenetics and the serotonin system: Initial studies and future directions

European Journal of Pharmacology

Volumn 410, Issue 2-3, 2000, Pages 165-181

  Veenstra VanderWeele, Jeremy ^a   Anderson, George M ^b   Cook Jr , Edwin H ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); 5 HT (5 hydroxytryptamine, serotonin) reuptake inhibitor; 5 HT (5 hydroxytryptamine, serotonin) transporter; 5 HT receptor; Clozapine; Monoamine oxidase; Pharmacogenetics; Selective; Tryptophan hydroxylase

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); BUSPIRONE; CLOZAPINE; LYSERGIDE; ONDANSETRON; PINDOLOL; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TRYPTOPHAN HYDROXYLASE; ZACOPRIDE;

AGGRESSION; ALCOHOLISM; ARTICLE; AUTISM; CHROMOSOMAL LOCALIZATION; DEPRESSION; DNA POLYMORPHISM; GENE CONTROL; GENETIC CODE; GENOTYPE; HUMAN; NEUROBIOLOGY; NEUROPHARMACOLOGY; NEUROPSYCHIATRY; NONHUMAN; OBSESSION; PHARMACOGENETICS; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM;

ANIMALS; HUMANS; PHARMACOGENETICS; RECEPTORS, SEROTONIN; SEROTONIN;

EID: 0034723057     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00814-1     Document Type: Article

References (153)

1. Serotonin and hallucinogens
2. Transmission-disequilibrium tests for quantitative traits
3. Pharmacogenetics: Promise and potential in child and adolescent psychiatry
4. Association between clozapine response and allelic variation in 5-HT2A receptor gene
5. Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response
6. The serotonin transporter and clozapine response
7. Pharmacogenetic prediction of clozapine response
8. The power of genomic control
9. Localization to chromosome 10 of a locus influencing morphine analgesia in crosses derived from C57BL/6 and DBA/2 strains
10. Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression
11. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice
12. Pharmacogenetics of antidepressants: Clinical aspects
13. Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene
14. Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response
15. Family-based association study between bipolar disorder and DRD2, DRD4, DAT, and SERT in Sardinia
16. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A
17. Anxiety, motor activation, and maternal-infant interactions in 5HT1B knockout mice
18. Binding properties of the naturally occurring human 5-HT1A receptor variant with the Ile28Val substitution in the extracellular domain
19. Modified ligand binding to the naturally occurring Cys-124 variant of the human serotonin 5-HT1B receptor
20. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA
21. Ondansetron - The first of a new class of antiemetic agents
22. Effects of physical training on functional activity of 5-HT1B receptors in rat central nervous system: Role of 5-HT-moduline
23. Neurogenetic adaptive mechanisms in alcoholism
24. The serotonin system in autism
25. Evidence of linkage between the serotonin transporter and autistic disorder
26. Genetic animal models of alcohol and drug abuse
27. Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors
28. 5-HT1A receptor agonists: Recent developments and controversial issues
29. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder
30. Current and emerging second-generation triptans in acute migraine therapy: A comparative review
31. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment
32. A family-based analysis of whether the functional promoter alleles of the serotonin transporter gene HTT affect the risk for alcohol dependence
33. Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: Identification of two naturally occurring receptor variants and association analysis in schizophrenia
34. Serotonin transporter (5-HTT) gene and bipolar affective disorder
35. The transmission/disequilibrium test: History, subdivision, and admixture
36. An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells
37. Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees
38. Serotonin and the heart
39. Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse
40. Population studies of polymorphisms of the serotonin transporter protein gene
41. Serotonin transporter gene (HTTLPR) is not in linkage disequilibrium with prepubertal and early adolescent bipolarity
42. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents
43. Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor
44. 5-Hydroxytryptamine-moduline: A novel endogenous peptide involved in the control of anxiety
45. Lithium response and genetics of affective disorders
46. Pharmacogenetic evidence for the involvement of 5-hydroxytryptamine (serotonin)-1B receptors in the mediation of morphine antinociceptive sensitivity
47. No association or linkage between the 5-HT2a/T102C polymorphism and schizophrenia in Irish families
48. Allelic variation of human serotonin transporter gene expression
49. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity
50. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice
51. An association study between alcoholism and the serotonergic receptor genes
52. Serotonin transporter gene and schizophrenia: Evidence for association/linkage disequilibrium in families with affected siblings
53. Association of monoamine oxidase A alleles with alcoholism among male Chinese in Taiwan
54. Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior
55. Association between drinking-related antisocial behavior and a polymorphism in the serotonin transporter gene in a Japanese population
56. The 5′ region of the tryptophan hydroxylase gene: Mutation search and association study with alcoholism
57. A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers
58. Global variation of a 40-bp VNTR in the 3′-untranslated region of the dopamine transporter gene (SLC6A3)
59. Serotonin 5-HT2C receptor stimulates cyclic GMP formation in choroid plexus
60. Promoter prognostication: The serotonin transporter gene and antidepressant response
61. Serotonin transporter gene polymorphism and antidepressant response
62. Bipolar disorder and the serotonin transporter gene: A family-based association study
63. Serotonin transporter (5-HTT) gene variants associated with autism?
64. No association between the serotonin transporter promoter region (5-HTTLPR) and the dopamine D3 receptor (BalI D3DR) polymorphisms and heroin addiction
65. Receptor mechanisms involved in the 5-HT-induced inotropic action in the rat isolated atrium
66. Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2C receptor gene (HTR2C)
67. Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations
68. HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses
69. Physical mapping of the serotonin 5-HT(7) receptor gene (HTR7) to chromosome 10 and pseudogene (HTR7P) to chromosome 12, and testing of linkage disequilibrium between HTR7 and autistic disorder
70. Behavioral effects of tryptophan depletion in seasonal affective disorder associated with the serotonin transporter gene?
71. Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence
72. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
73. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice
74. Clinical effects of clozapine in chronic schizophrenia: Response to treatment and predictors of outcome
75. Aggression, suicidality, and serotonin
76. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels
77. Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice
78. The spectrum of behaviors influenced by serotonin
79. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo
80. Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families
81. Clozapine response and the 5HT2CCys23Ser polymorphism
82. 5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze
83. Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients
84. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide
85. Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients
86. Pharmacogenetics of antipsychotic treatment: Lessons learned from clozapine
87. Role of the serotonin transporter promoter polymorphism in anxiety-related traits
88. Pindolol augmentation of antidepressant therapy
89. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder
90. The role of serotonin in antipsychotic drug action
91. The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs
92. Possible relationship between outcome in primary affective disorders treated with lithium and family history
93. Is the 5-HT(1Dbeta) receptor gene implicated in the pathogenesis of obsessive-compulsive disorder?
94. Lack of linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and bipolar disorder
95. Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor vs. human 5-HT3 receptor
96. Association of a polymorphism of the 5HT2A receptor gene promoter region with alcohol dependence
97. Two naturally occurring amino acid substitutions in the human 5HT1A receptor: 5HT1A-22 Gly-Ser and 5HT1A-28 Ile-Val
98. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism
99. Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7
100. Contractile 5-HT1B receptors in human cerebral arteries: Pharmacological characterization and localization with immunocytochemistry
101. Pharmacogenetic response to antidepressants in a multicase family with affective disorder
102. Association and linkage of anxiety-related traits with a functional polymorphism of the serotonin transporter gene regulatory region in israeli sibling pairs
103. Two naturally occurring amino acid substitutions of the 5-HT2A receptor: Similar prevalence in patients with seasonal affective disorder and controls
104. A naturally occurring amino acid substitution of the human serotonin 5-HT2A receptor influences amplitude and timing of intracellular calcium mobilization
105. Serotonin2C receptors and serotonin2C receptor-mediated phosphoinositide hydrolysis in the brain of alcohol-preferring and alcohol-nonpreferring rats
106. Increased anxiety of mice lacking the serotonin1A receptor
107. Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites
108. Exclusion of close linkage between the synaptic vesicular monoamine transporter locus and schizophrenia spectrum disorders
109. Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samples
110. Effect of 5-HT4 receptor stimulation on the pacemaker current I(f) in human isolated atrial myocytes
111. Association mapping in structured populations
112. Serotonin receptor 1A knockout: An animal model of anxiety-related disorder
113. The recombinant 5-HT1A receptor: G protein coupling and signalling pathways
114. Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor
115. Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter
116. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor
117. Agonist-promoted down-regulation and functional desensitization in two naturally occurring variants of the human serotonin1A receptor
118. Identification of four variants in the tryptophan hydroxylase promoter and association to behavior
119. A functional polymorphism in the monoamine oxidase A gene promoter
120. Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism
121. Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence
122. Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder
123. 5-Hydroxytryptamine and functional bowel disorders
124. Enhanced aggressive behavior in mice lacking 5-HT1B receptor
125. Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: A pilot study
126. Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders
127. Ketanserin and tetrabenazine abolish aggression in mice lacking monoamine oxidase A
128. Genetic inactivation of the Serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety
129. Outcomes on lithium treatment as a tool for genetic studies in affective disorders
130. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine
131. Association between clozapine response and allelic variation in the 5-HT2C receptor gene
132. The TDT and other family-based tests for linkage disequilibrium and association
133. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM)
134. A sibship test for linkage in the presence of association: The sib transmission/disequilibrium test
135. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter
136. VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity
137. Evidence for an association between heroin dependence and a VNTR polymorphism at the serotonin transporter locus
138. Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors
139. Mapping disease genes: Family-based association studies
140. Effect of 5-HT(1B) receptor ligands on self-administration of ethanol in an operant procedure in rats
141. Role of the serotonin transporter in the behavioral expression of autism
142. Differential quantal release of histamine and 5-hydroxytryptamine from mast cells of vesicular monoamine transporter 2 knockout mice
143. Tryptophan hydroxylase gene polymorphism (A218C) and suicidal behaviors
144. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide
145. MAOA: Association and linkage studies with lithium responsive bipolar disorder
146. High ethanol tolerance in young adults is associated with the low-activity variant of the promoter of the human serotonin transporter gene
147. Molecular genetics of substance abuse vulnerability: A current approach
148. Reduced satiating effect of d-fenfluramine in serotonin 5-HT(2C) receptor mutant mice
149. A logistic regression based extension of the TDT for continuous and categorical traits
150. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine
151. Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine
152. Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes
153. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene